database,exposure,outcomeCategory,Disease,denomPatid,denomIndexExp,timeWindow,numer,prevPct
MPCD,DMARD,Cancer,Hematologic Cancer,421,481,12 months,1,0.2079002079
MPCD,DMARD,Cancer,Hematologic Cancer,421,481,24 months,1,0.2079002079
MPCD,DMARD,Cancer,Hematologic Cancer,421,481,36 months,1,0.2079002079
MPCD,DMARD,Cancer,Hematologic Cancer,421,481,AS cohort entry to exposure,1,0.2079002079
MPCD,DMARD,Cancer,Solid Cancer,421,481,12 months,7,1.4553014553
MPCD,DMARD,Cancer,Solid Cancer,421,481,24 months,13,2.7027027027
MPCD,DMARD,Cancer,Solid Cancer,421,481,36 months,13,2.7027027027
MPCD,DMARD,Cancer,Solid Cancer,421,481,AS cohort entry to exposure,6,1.2474012474
MPCD,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,421,481,12 months,3,0.6237006237
MPCD,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,421,481,24 months,3,0.6237006237
MPCD,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,421,481,36 months,4,0.8316008316
MPCD,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,421,481,AS cohort entry to exposure,2,0.4158004158
MPCD,DMARD,Infection,Hospitalized infection,421,481,12 months,6,1.2474012474
MPCD,DMARD,Infection,Hospitalized infection,421,481,24 months,11,2.2869022869
MPCD,DMARD,Infection,Hospitalized infection,421,481,36 months,14,2.9106029106
MPCD,DMARD,Infection,Hospitalized infection,421,481,AS cohort entry to exposure,7,1.4553014553
MPCD,DMARD,Infection,Opportunistic infection,421,481,12 months,5,1.0395010395
MPCD,DMARD,Infection,Opportunistic infection,421,481,24 months,9,1.8711018711
MPCD,DMARD,Infection,Opportunistic infection,421,481,36 months,13,2.7027027027
MPCD,DMARD,Infection,Opportunistic infection,421,481,AS cohort entry to exposure,3,0.6237006237
MPCD,DMARD,Inflammatory bowel disease,Crohn’s Disease,421,481,12 months,19,3.9501039501
MPCD,DMARD,Inflammatory bowel disease,Crohn’s Disease,421,481,24 months,21,4.3659043659
MPCD,DMARD,Inflammatory bowel disease,Crohn’s Disease,421,481,36 months,21,4.3659043659
MPCD,DMARD,Inflammatory bowel disease,Crohn’s Disease,421,481,AS cohort entry to exposure,14,2.9106029106
MPCD,DMARD,Inflammatory bowel disease,Ulcerative Colitis,421,481,12 months,11,2.2869022869
MPCD,DMARD,Inflammatory bowel disease,Ulcerative Colitis,421,481,24 months,13,2.7027027027
MPCD,DMARD,Inflammatory bowel disease,Ulcerative Colitis,421,481,36 months,13,2.7027027027
MPCD,DMARD,Inflammatory bowel disease,Ulcerative Colitis,421,481,AS cohort entry to exposure,7,1.4553014553
MPCD,DMARD,Kidney disease,IgA nephropathy,421,481,12 months,1,0.2079002079
MPCD,DMARD,Kidney disease,IgA nephropathy,421,481,24 months,1,0.2079002079
MPCD,DMARD,Kidney disease,IgA nephropathy,421,481,36 months,1,0.2079002079
MPCD,DMARD,Kidney disease,IgA nephropathy,421,481,AS cohort entry to exposure,1,0.2079002079
MPCD,DMARD,Kidney disease,Nephrotic syndrome,421,481,12 months,1,0.2079002079
MPCD,DMARD,Kidney disease,Nephrotic syndrome,421,481,24 months,1,0.2079002079
MPCD,DMARD,Kidney disease,Nephrotic syndrome,421,481,36 months,1,0.2079002079
MPCD,DMARD,Kidney disease,Nephrotic syndrome,421,481,AS cohort entry to exposure,0,0
MPCD,DMARD,Lung disease,Restrictive lung disease ,421,481,12 months,2,0.4158004158
MPCD,DMARD,Lung disease,Restrictive lung disease ,421,481,24 months,3,0.6237006237
MPCD,DMARD,Lung disease,Restrictive lung disease ,421,481,36 months,4,0.8316008316
MPCD,DMARD,Lung disease,Restrictive lung disease ,421,481,AS cohort entry to exposure,2,0.4158004158
MPCD,DMARD,Osteoporotic fracture,Clinical vertebral fracture,421,481,12 months,2,0.4158004158
MPCD,DMARD,Osteoporotic fracture,Clinical vertebral fracture,421,481,24 months,3,0.6237006237
MPCD,DMARD,Osteoporotic fracture,Clinical vertebral fracture,421,481,36 months,4,0.8316008316
MPCD,DMARD,Osteoporotic fracture,Clinical vertebral fracture,421,481,AS cohort entry to exposure,1,0.2079002079
MPCD,DMARD,Osteoporotic fracture,Non-vertebral osteoporotic fracture,421,481,12 months,4,0.8316008316
MPCD,DMARD,Osteoporotic fracture,Non-vertebral osteoporotic fracture,421,481,24 months,8,1.6632016632
MPCD,DMARD,Osteoporotic fracture,Non-vertebral osteoporotic fracture,421,481,36 months,11,2.2869022869
MPCD,DMARD,Osteoporotic fracture,Non-vertebral osteoporotic fracture,421,481,AS cohort entry to exposure,5,1.0395010395
MPCD,DMARD,PsO/PsA,Psoriasis,421,481,12 months,7,1.4553014553
MPCD,DMARD,PsO/PsA,Psoriasis,421,481,24 months,11,2.2869022869
MPCD,DMARD,PsO/PsA,Psoriasis,421,481,36 months,14,2.9106029106
MPCD,DMARD,PsO/PsA,Psoriasis,421,481,AS cohort entry to exposure,6,1.2474012474
MPCD,DMARD,PsO/PsA,Psoriatic arthritis,421,481,12 months,26,5.4054054054
MPCD,DMARD,PsO/PsA,Psoriatic arthritis,421,481,24 months,30,6.237006237
MPCD,DMARD,PsO/PsA,Psoriatic arthritis,421,481,36 months,31,6.4449064449
MPCD,DMARD,PsO/PsA,Psoriatic arthritis,421,481,AS cohort entry to exposure,21,4.3659043659
MPCD,DMARD,Uveitis,Uveitis,421,481,12 months,35,7.2765072765
MPCD,DMARD,Uveitis,Uveitis,421,481,24 months,40,8.316008316
MPCD,DMARD,Uveitis,Uveitis,421,481,36 months,42,8.7318087318
MPCD,DMARD,Uveitis,Uveitis,421,481,AS cohort entry to exposure,28,5.8212058212
MPCD,NSAID or no exposure,Cancer,Hematologic Cancer,2083,2593,12 months,13,0.5013497879
MPCD,NSAID or no exposure,Cancer,Hematologic Cancer,2083,2593,24 months,18,0.6941766294
MPCD,NSAID or no exposure,Cancer,Hematologic Cancer,2083,2593,36 months,19,0.7327419977
MPCD,NSAID or no exposure,Cancer,Hematologic Cancer,2083,2593,AS cohort entry to exposure,2,0.0771307366
MPCD,NSAID or no exposure,Cancer,Solid Cancer,2083,2593,12 months,110,4.2421905129
MPCD,NSAID or no exposure,Cancer,Solid Cancer,2083,2593,24 months,149,5.7462398766
MPCD,NSAID or no exposure,Cancer,Solid Cancer,2083,2593,36 months,163,6.2861550328
MPCD,NSAID or no exposure,Cancer,Solid Cancer,2083,2593,AS cohort entry to exposure,42,1.6197454686
MPCD,NSAID or no exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,2083,2593,12 months,41,1.5811801003
MPCD,NSAID or no exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,2083,2593,24 months,55,2.1210952565
MPCD,NSAID or no exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,2083,2593,36 months,62,2.3910528346
MPCD,NSAID or no exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,2083,2593,AS cohort entry to exposure,7,0.2699575781
MPCD,NSAID or no exposure,Cardiac disease,Conduction Block,2083,2593,12 months,23,0.8870034709
MPCD,NSAID or no exposure,Cardiac disease,Conduction Block,2083,2593,24 months,29,1.1183956807
MPCD,NSAID or no exposure,Cardiac disease,Conduction Block,2083,2593,36 months,34,1.3112225222
MPCD,NSAID or no exposure,Cardiac disease,Conduction Block,2083,2593,AS cohort entry to exposure,6,0.2313922098
MPCD,NSAID or no exposure,Cardiac disease,Myocardial infarction,2083,2593,12 months,13,0.5013497879
MPCD,NSAID or no exposure,Cardiac disease,Myocardial infarction,2083,2593,24 months,24,0.9255688392
MPCD,NSAID or no exposure,Cardiac disease,Myocardial infarction,2083,2593,36 months,25,0.9641342075
MPCD,NSAID or no exposure,Cardiac disease,Myocardial infarction,2083,2593,AS cohort entry to exposure,1,0.0385653683
MPCD,NSAID or no exposure,Infection,Hospitalized infection,2083,2593,12 months,145,5.5919784034
MPCD,NSAID or no exposure,Infection,Hospitalized infection,2083,2593,24 months,186,7.1731585037
MPCD,NSAID or no exposure,Infection,Hospitalized infection,2083,2593,36 months,197,7.597377555
MPCD,NSAID or no exposure,Infection,Hospitalized infection,2083,2593,AS cohort entry to exposure,75,2.8924026224
MPCD,NSAID or no exposure,Infection,Opportunistic infection,2083,2593,12 months,21,0.8098727343
MPCD,NSAID or no exposure,Infection,Opportunistic infection,2083,2593,24 months,25,0.9641342075
MPCD,NSAID or no exposure,Infection,Opportunistic infection,2083,2593,36 months,30,1.156961049
MPCD,NSAID or no exposure,Infection,Opportunistic infection,2083,2593,AS cohort entry to exposure,8,0.3085229464
MPCD,NSAID or no exposure,Inflammatory bowel disease,Crohn’s Disease,2083,2593,12 months,88,3.3937524103
MPCD,NSAID or no exposure,Inflammatory bowel disease,Crohn’s Disease,2083,2593,24 months,100,3.8565368299
MPCD,NSAID or no exposure,Inflammatory bowel disease,Crohn’s Disease,2083,2593,36 months,107,4.126494408
MPCD,NSAID or no exposure,Inflammatory bowel disease,Crohn’s Disease,2083,2593,AS cohort entry to exposure,37,1.4269186271
MPCD,NSAID or no exposure,Inflammatory bowel disease,Ulcerative Colitis,2083,2593,12 months,48,1.8511376784
MPCD,NSAID or no exposure,Inflammatory bowel disease,Ulcerative Colitis,2083,2593,24 months,56,2.1596606248
MPCD,NSAID or no exposure,Inflammatory bowel disease,Ulcerative Colitis,2083,2593,36 months,57,2.1982259931
MPCD,NSAID or no exposure,Inflammatory bowel disease,Ulcerative Colitis,2083,2593,AS cohort entry to exposure,24,0.9255688392
MPCD,NSAID or no exposure,Kidney disease,Amyloidosis,2083,2593,12 months,1,0.0385653683
MPCD,NSAID or no exposure,Kidney disease,Amyloidosis,2083,2593,24 months,2,0.0771307366
MPCD,NSAID or no exposure,Kidney disease,Amyloidosis,2083,2593,36 months,3,0.1156961049
MPCD,NSAID or no exposure,Kidney disease,Amyloidosis,2083,2593,AS cohort entry to exposure,0,0
MPCD,NSAID or no exposure,Kidney disease,IgA nephropathy,2083,2593,12 months,1,0.0385653683
MPCD,NSAID or no exposure,Kidney disease,IgA nephropathy,2083,2593,24 months,4,0.1542614732
MPCD,NSAID or no exposure,Kidney disease,IgA nephropathy,2083,2593,36 months,6,0.2313922098
MPCD,NSAID or no exposure,Kidney disease,IgA nephropathy,2083,2593,AS cohort entry to exposure,1,0.0385653683
MPCD,NSAID or no exposure,Kidney disease,Nephrotic syndrome,2083,2593,12 months,0,0
MPCD,NSAID or no exposure,Kidney disease,Nephrotic syndrome,2083,2593,24 months,1,0.0385653683
MPCD,NSAID or no exposure,Kidney disease,Nephrotic syndrome,2083,2593,36 months,1,0.0385653683
MPCD,NSAID or no exposure,Kidney disease,Nephrotic syndrome,2083,2593,AS cohort entry to exposure,0,0
MPCD,NSAID or no exposure,Lung disease,Apical Pulmonary fibrosis,2083,2593,12 months,0,0
MPCD,NSAID or no exposure,Lung disease,Apical Pulmonary fibrosis,2083,2593,24 months,1,0.0385653683
MPCD,NSAID or no exposure,Lung disease,Apical Pulmonary fibrosis,2083,2593,36 months,1,0.0385653683
MPCD,NSAID or no exposure,Lung disease,Apical Pulmonary fibrosis,2083,2593,AS cohort entry to exposure,0,0
MPCD,NSAID or no exposure,Lung disease,Interstitial lung disease,2083,2593,12 months,2,0.0771307366
MPCD,NSAID or no exposure,Lung disease,Interstitial lung disease,2083,2593,24 months,4,0.1542614732
MPCD,NSAID or no exposure,Lung disease,Interstitial lung disease,2083,2593,36 months,4,0.1542614732
MPCD,NSAID or no exposure,Lung disease,Interstitial lung disease,2083,2593,AS cohort entry to exposure,1,0.0385653683
MPCD,NSAID or no exposure,Lung disease,Restrictive lung disease ,2083,2593,12 months,40,1.542614732
MPCD,NSAID or no exposure,Lung disease,Restrictive lung disease ,2083,2593,24 months,63,2.4296182029
MPCD,NSAID or no exposure,Lung disease,Restrictive lung disease ,2083,2593,36 months,70,2.6995757809
MPCD,NSAID or no exposure,Lung disease,Restrictive lung disease ,2083,2593,AS cohort entry to exposure,20,0.771307366
MPCD,NSAID or no exposure,Neurological Disease,Cauda Equina syndrome,2083,2593,12 months,4,0.1542614732
MPCD,NSAID or no exposure,Neurological Disease,Cauda Equina syndrome,2083,2593,24 months,5,0.1928268415
MPCD,NSAID or no exposure,Neurological Disease,Cauda Equina syndrome,2083,2593,36 months,5,0.1928268415
MPCD,NSAID or no exposure,Neurological Disease,Cauda Equina syndrome,2083,2593,AS cohort entry to exposure,3,0.1156961049
MPCD,NSAID or no exposure,Neurological Disease,Spinal Cord compression,2083,2593,12 months,6,0.2313922098
MPCD,NSAID or no exposure,Neurological Disease,Spinal Cord compression,2083,2593,24 months,8,0.3085229464
MPCD,NSAID or no exposure,Neurological Disease,Spinal Cord compression,2083,2593,36 months,10,0.385653683
MPCD,NSAID or no exposure,Neurological Disease,Spinal Cord compression,2083,2593,AS cohort entry to exposure,4,0.1542614732
MPCD,NSAID or no exposure,Osteoporotic fracture,Clinical vertebral fracture,2083,2593,12 months,69,2.6610104126
MPCD,NSAID or no exposure,Osteoporotic fracture,Clinical vertebral fracture,2083,2593,24 months,74,2.8538372541
MPCD,NSAID or no exposure,Osteoporotic fracture,Clinical vertebral fracture,2083,2593,36 months,79,3.0466640956
MPCD,NSAID or no exposure,Osteoporotic fracture,Clinical vertebral fracture,2083,2593,AS cohort entry to exposure,20,0.771307366
MPCD,NSAID or no exposure,Osteoporotic fracture,Non-vertebral osteoporotic fracture,2083,2593,12 months,86,3.3166216737
MPCD,NSAID or no exposure,Osteoporotic fracture,Non-vertebral osteoporotic fracture,2083,2593,24 months,119,4.5892788276
MPCD,NSAID or no exposure,Osteoporotic fracture,Non-vertebral osteoporotic fracture,2083,2593,36 months,136,5.2448900887
MPCD,NSAID or no exposure,Osteoporotic fracture,Non-vertebral osteoporotic fracture,2083,2593,AS cohort entry to exposure,33,1.2726571539
MPCD,NSAID or no exposure,PsO/PsA,Psoriasis,2083,2593,12 months,49,1.8897030467
MPCD,NSAID or no exposure,PsO/PsA,Psoriasis,2083,2593,24 months,66,2.5453143078
MPCD,NSAID or no exposure,PsO/PsA,Psoriasis,2083,2593,36 months,71,2.7381411492
MPCD,NSAID or no exposure,PsO/PsA,Psoriasis,2083,2593,AS cohort entry to exposure,26,1.0026995758
MPCD,NSAID or no exposure,PsO/PsA,Psoriatic arthritis,2083,2593,12 months,63,2.4296182029
MPCD,NSAID or no exposure,PsO/PsA,Psoriatic arthritis,2083,2593,24 months,76,2.9309679907
MPCD,NSAID or no exposure,PsO/PsA,Psoriatic arthritis,2083,2593,36 months,86,3.3166216737
MPCD,NSAID or no exposure,PsO/PsA,Psoriatic arthritis,2083,2593,AS cohort entry to exposure,29,1.1183956807
MPCD,NSAID or no exposure,Uveitis,Uveitis,2083,2593,12 months,162,6.2475896645
MPCD,NSAID or no exposure,Uveitis,Uveitis,2083,2593,24 months,190,7.3274199769
MPCD,NSAID or no exposure,Uveitis,Uveitis,2083,2593,36 months,202,7.7902043965
MPCD,NSAID or no exposure,Uveitis,Uveitis,2083,2593,AS cohort entry to exposure,82,3.1623602005
MPCD,TNF,Cancer,Hematologic Cancer,1107,1279,12 months,4,0.3127443315
MPCD,TNF,Cancer,Hematologic Cancer,1107,1279,24 months,5,0.3909304144
MPCD,TNF,Cancer,Hematologic Cancer,1107,1279,36 months,5,0.3909304144
MPCD,TNF,Cancer,Hematologic Cancer,1107,1279,AS cohort entry to exposure,4,0.3127443315
MPCD,TNF,Cancer,Solid Cancer,1107,1279,12 months,33,2.5801407349
MPCD,TNF,Cancer,Solid Cancer,1107,1279,24 months,41,3.205629398
MPCD,TNF,Cancer,Solid Cancer,1107,1279,36 months,44,3.4401876466
MPCD,TNF,Cancer,Solid Cancer,1107,1279,AS cohort entry to exposure,19,1.4855355747
MPCD,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1107,1279,12 months,22,1.7200938233
MPCD,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1107,1279,24 months,27,2.1110242377
MPCD,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1107,1279,36 months,28,2.1892103206
MPCD,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1107,1279,AS cohort entry to exposure,18,1.4073494918
MPCD,TNF,Cardiac disease,Conduction Block,1107,1279,12 months,3,0.2345582486
MPCD,TNF,Cardiac disease,Conduction Block,1107,1279,24 months,3,0.2345582486
MPCD,TNF,Cardiac disease,Conduction Block,1107,1279,36 months,3,0.2345582486
MPCD,TNF,Cardiac disease,Conduction Block,1107,1279,AS cohort entry to exposure,1,0.0781860829
MPCD,TNF,Cardiac disease,Myocardial infarction,1107,1279,12 months,4,0.3127443315
MPCD,TNF,Cardiac disease,Myocardial infarction,1107,1279,24 months,7,0.5473025801
MPCD,TNF,Cardiac disease,Myocardial infarction,1107,1279,36 months,7,0.5473025801
MPCD,TNF,Cardiac disease,Myocardial infarction,1107,1279,AS cohort entry to exposure,3,0.2345582486
MPCD,TNF,Infection,Hospitalized infection,1107,1279,12 months,13,1.0164190774
MPCD,TNF,Infection,Hospitalized infection,1107,1279,24 months,22,1.7200938233
MPCD,TNF,Infection,Hospitalized infection,1107,1279,36 months,24,1.8764659891
MPCD,TNF,Infection,Hospitalized infection,1107,1279,AS cohort entry to exposure,14,1.0946051603
MPCD,TNF,Infection,Opportunistic infection,1107,1279,12 months,17,1.3291634089
MPCD,TNF,Infection,Opportunistic infection,1107,1279,24 months,22,1.7200938233
MPCD,TNF,Infection,Opportunistic infection,1107,1279,36 months,23,1.7982799062
MPCD,TNF,Infection,Opportunistic infection,1107,1279,AS cohort entry to exposure,10,0.7818608288
MPCD,TNF,Inflammatory bowel disease,Crohn’s Disease,1107,1279,12 months,74,5.7857701329
MPCD,TNF,Inflammatory bowel disease,Crohn’s Disease,1107,1279,24 months,82,6.4112587959
MPCD,TNF,Inflammatory bowel disease,Crohn’s Disease,1107,1279,36 months,85,6.6458170446
MPCD,TNF,Inflammatory bowel disease,Crohn’s Disease,1107,1279,AS cohort entry to exposure,65,5.082095387
MPCD,TNF,Inflammatory bowel disease,Ulcerative Colitis,1107,1279,12 months,39,3.0492572322
MPCD,TNF,Inflammatory bowel disease,Ulcerative Colitis,1107,1279,24 months,45,3.5183737295
MPCD,TNF,Inflammatory bowel disease,Ulcerative Colitis,1107,1279,36 months,47,3.6747458952
MPCD,TNF,Inflammatory bowel disease,Ulcerative Colitis,1107,1279,AS cohort entry to exposure,27,2.1110242377
MPCD,TNF,Kidney disease,IgA nephropathy,1107,1279,12 months,4,0.3127443315
MPCD,TNF,Kidney disease,IgA nephropathy,1107,1279,24 months,4,0.3127443315
MPCD,TNF,Kidney disease,IgA nephropathy,1107,1279,36 months,4,0.3127443315
MPCD,TNF,Kidney disease,IgA nephropathy,1107,1279,AS cohort entry to exposure,1,0.0781860829
MPCD,TNF,Kidney disease,Nephrotic syndrome,1107,1279,12 months,2,0.1563721658
MPCD,TNF,Kidney disease,Nephrotic syndrome,1107,1279,24 months,2,0.1563721658
MPCD,TNF,Kidney disease,Nephrotic syndrome,1107,1279,36 months,2,0.1563721658
MPCD,TNF,Kidney disease,Nephrotic syndrome,1107,1279,AS cohort entry to exposure,0,0
MPCD,TNF,Lung disease,Restrictive lung disease ,1107,1279,12 months,9,0.7036747459
MPCD,TNF,Lung disease,Restrictive lung disease ,1107,1279,24 months,15,1.1727912432
MPCD,TNF,Lung disease,Restrictive lung disease ,1107,1279,36 months,17,1.3291634089
MPCD,TNF,Lung disease,Restrictive lung disease ,1107,1279,AS cohort entry to exposure,10,0.7818608288
MPCD,TNF,Neurological Disease,Spinal Cord compression,1107,1279,12 months,2,0.1563721658
MPCD,TNF,Neurological Disease,Spinal Cord compression,1107,1279,24 months,2,0.1563721658
MPCD,TNF,Neurological Disease,Spinal Cord compression,1107,1279,36 months,2,0.1563721658
MPCD,TNF,Neurological Disease,Spinal Cord compression,1107,1279,AS cohort entry to exposure,0,0
MPCD,TNF,Osteoporotic fracture,Clinical vertebral fracture,1107,1279,12 months,17,1.3291634089
MPCD,TNF,Osteoporotic fracture,Clinical vertebral fracture,1107,1279,24 months,19,1.4855355747
MPCD,TNF,Osteoporotic fracture,Clinical vertebral fracture,1107,1279,36 months,19,1.4855355747
MPCD,TNF,Osteoporotic fracture,Clinical vertebral fracture,1107,1279,AS cohort entry to exposure,11,0.8600469116
MPCD,TNF,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1107,1279,12 months,26,2.0328381548
MPCD,TNF,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1107,1279,24 months,37,2.8928850665
MPCD,TNF,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1107,1279,36 months,38,2.9710711493
MPCD,TNF,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1107,1279,AS cohort entry to exposure,18,1.4073494918
MPCD,TNF,PsO/PsA,Psoriasis,1107,1279,12 months,55,4.3002345582
MPCD,TNF,PsO/PsA,Psoriasis,1107,1279,24 months,67,5.2384675528
MPCD,TNF,PsO/PsA,Psoriasis,1107,1279,36 months,72,5.6293979672
MPCD,TNF,PsO/PsA,Psoriasis,1107,1279,AS cohort entry to exposure,37,2.8928850665
MPCD,TNF,PsO/PsA,Psoriatic arthritis,1107,1279,12 months,83,6.4894448788
MPCD,TNF,PsO/PsA,Psoriatic arthritis,1107,1279,24 months,98,7.662236122
MPCD,TNF,PsO/PsA,Psoriatic arthritis,1107,1279,36 months,103,8.0531665364
MPCD,TNF,PsO/PsA,Psoriatic arthritis,1107,1279,AS cohort entry to exposure,70,5.4730258014
MPCD,TNF,Uveitis,Uveitis,1107,1279,12 months,108,8.4440969507
MPCD,TNF,Uveitis,Uveitis,1107,1279,24 months,121,9.4605160281
MPCD,TNF,Uveitis,Uveitis,1107,1279,36 months,126,9.8514464425
MPCD,TNF,Uveitis,Uveitis,1107,1279,AS cohort entry to exposure,90,7.036747459
Marketscan,DMARD,Cancer,Hematologic Cancer,1799,2045,12 months,16,0.782396088
Marketscan,DMARD,Cancer,Hematologic Cancer,1799,2045,24 months,22,1.075794621
Marketscan,DMARD,Cancer,Hematologic Cancer,1799,2045,36 months,23,1.1246943765
Marketscan,DMARD,Cancer,Hematologic Cancer,1799,2045,AS cohort entry to exposure,12,0.586797066
Marketscan,DMARD,Cancer,Non Melanoma Skin Cancer,1799,2045,12 months,10,0.488997555
Marketscan,DMARD,Cancer,Non Melanoma Skin Cancer,1799,2045,24 months,22,1.075794621
Marketscan,DMARD,Cancer,Non Melanoma Skin Cancer,1799,2045,36 months,27,1.3202933985
Marketscan,DMARD,Cancer,Non Melanoma Skin Cancer,1799,2045,AS cohort entry to exposure,6,0.293398533
Marketscan,DMARD,Cancer,Solid Cancer,1799,2045,12 months,85,4.1564792176
Marketscan,DMARD,Cancer,Solid Cancer,1799,2045,24 months,103,5.0366748166
Marketscan,DMARD,Cancer,Solid Cancer,1799,2045,36 months,115,5.6234718826
Marketscan,DMARD,Cancer,Solid Cancer,1799,2045,AS cohort entry to exposure,59,2.8850855746
Marketscan,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1799,2045,12 months,18,0.880195599
Marketscan,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1799,2045,24 months,28,1.369193154
Marketscan,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1799,2045,36 months,34,1.662591687
Marketscan,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1799,2045,AS cohort entry to exposure,13,0.6356968215
Marketscan,DMARD,Cardiac disease,Conduction Block,1799,2045,12 months,23,1.1246943765
Marketscan,DMARD,Cardiac disease,Conduction Block,1799,2045,24 months,30,1.466992665
Marketscan,DMARD,Cardiac disease,Conduction Block,1799,2045,36 months,32,1.564792176
Marketscan,DMARD,Cardiac disease,Conduction Block,1799,2045,AS cohort entry to exposure,13,0.6356968215
Marketscan,DMARD,Cardiac disease,Myocardial infarction,1799,2045,12 months,3,0.1466992665
Marketscan,DMARD,Cardiac disease,Myocardial infarction,1799,2045,24 months,6,0.293398533
Marketscan,DMARD,Cardiac disease,Myocardial infarction,1799,2045,36 months,8,0.391198044
Marketscan,DMARD,Cardiac disease,Myocardial infarction,1799,2045,AS cohort entry to exposure,5,0.2444987775
Marketscan,DMARD,Infection,Hospitalized infection,1799,2045,12 months,99,4.8410757946
Marketscan,DMARD,Infection,Hospitalized infection,1799,2045,24 months,142,6.9437652812
Marketscan,DMARD,Infection,Hospitalized infection,1799,2045,36 months,151,7.3838630807
Marketscan,DMARD,Infection,Hospitalized infection,1799,2045,AS cohort entry to exposure,88,4.3031784841
Marketscan,DMARD,Infection,Opportunistic infection,1799,2045,12 months,31,1.5158924205
Marketscan,DMARD,Infection,Opportunistic infection,1799,2045,24 months,45,2.2004889976
Marketscan,DMARD,Infection,Opportunistic infection,1799,2045,36 months,49,2.3960880196
Marketscan,DMARD,Infection,Opportunistic infection,1799,2045,AS cohort entry to exposure,22,1.075794621
Marketscan,DMARD,Inflammatory bowel disease,Crohn’s Disease,1799,2045,12 months,79,3.8630806846
Marketscan,DMARD,Inflammatory bowel disease,Crohn’s Disease,1799,2045,24 months,88,4.3031784841
Marketscan,DMARD,Inflammatory bowel disease,Crohn’s Disease,1799,2045,36 months,92,4.4987775061
Marketscan,DMARD,Inflammatory bowel disease,Crohn’s Disease,1799,2045,AS cohort entry to exposure,69,3.3740831296
Marketscan,DMARD,Inflammatory bowel disease,Ulcerative Colitis,1799,2045,12 months,53,2.5916870416
Marketscan,DMARD,Inflammatory bowel disease,Ulcerative Colitis,1799,2045,24 months,63,3.0806845966
Marketscan,DMARD,Inflammatory bowel disease,Ulcerative Colitis,1799,2045,36 months,67,3.2762836186
Marketscan,DMARD,Inflammatory bowel disease,Ulcerative Colitis,1799,2045,AS cohort entry to exposure,28,1.369193154
Marketscan,DMARD,Kidney disease,Amyloidosis,1799,2045,12 months,0,0
Marketscan,DMARD,Kidney disease,Amyloidosis,1799,2045,24 months,1,0.0488997555
Marketscan,DMARD,Kidney disease,Amyloidosis,1799,2045,36 months,1,0.0488997555
Marketscan,DMARD,Kidney disease,Amyloidosis,1799,2045,AS cohort entry to exposure,0,0
Marketscan,DMARD,Kidney disease,IgA nephropathy,1799,2045,12 months,1,0.0488997555
Marketscan,DMARD,Kidney disease,IgA nephropathy,1799,2045,24 months,1,0.0488997555
Marketscan,DMARD,Kidney disease,IgA nephropathy,1799,2045,36 months,1,0.0488997555
Marketscan,DMARD,Kidney disease,IgA nephropathy,1799,2045,AS cohort entry to exposure,1,0.0488997555
Marketscan,DMARD,Kidney disease,Nephrotic syndrome,1799,2045,12 months,1,0.0488997555
Marketscan,DMARD,Kidney disease,Nephrotic syndrome,1799,2045,24 months,2,0.097799511
Marketscan,DMARD,Kidney disease,Nephrotic syndrome,1799,2045,36 months,3,0.1466992665
Marketscan,DMARD,Kidney disease,Nephrotic syndrome,1799,2045,AS cohort entry to exposure,0,0
Marketscan,DMARD,Lung disease,Interstitial lung disease,1799,2045,12 months,3,0.1466992665
Marketscan,DMARD,Lung disease,Interstitial lung disease,1799,2045,24 months,4,0.195599022
Marketscan,DMARD,Lung disease,Interstitial lung disease,1799,2045,36 months,4,0.195599022
Marketscan,DMARD,Lung disease,Interstitial lung disease,1799,2045,AS cohort entry to exposure,2,0.097799511
Marketscan,DMARD,Lung disease,Restrictive lung disease ,1799,2045,12 months,15,0.7334963325
Marketscan,DMARD,Lung disease,Restrictive lung disease ,1799,2045,24 months,22,1.075794621
Marketscan,DMARD,Lung disease,Restrictive lung disease ,1799,2045,36 months,33,1.6136919315
Marketscan,DMARD,Lung disease,Restrictive lung disease ,1799,2045,AS cohort entry to exposure,18,0.880195599
Marketscan,DMARD,Neurological Disease,Cauda Equina syndrome,1799,2045,12 months,3,0.1466992665
Marketscan,DMARD,Neurological Disease,Cauda Equina syndrome,1799,2045,24 months,3,0.1466992665
Marketscan,DMARD,Neurological Disease,Cauda Equina syndrome,1799,2045,36 months,3,0.1466992665
Marketscan,DMARD,Neurological Disease,Cauda Equina syndrome,1799,2045,AS cohort entry to exposure,0,0
Marketscan,DMARD,Neurological Disease,Spinal Cord compression,1799,2045,12 months,4,0.195599022
Marketscan,DMARD,Neurological Disease,Spinal Cord compression,1799,2045,24 months,9,0.4400977995
Marketscan,DMARD,Neurological Disease,Spinal Cord compression,1799,2045,36 months,10,0.488997555
Marketscan,DMARD,Neurological Disease,Spinal Cord compression,1799,2045,AS cohort entry to exposure,2,0.097799511
Marketscan,DMARD,Osteoporotic fracture,Clinical vertebral fracture,1799,2045,12 months,17,0.8312958435
Marketscan,DMARD,Osteoporotic fracture,Clinical vertebral fracture,1799,2045,24 months,22,1.075794621
Marketscan,DMARD,Osteoporotic fracture,Clinical vertebral fracture,1799,2045,36 months,26,1.271393643
Marketscan,DMARD,Osteoporotic fracture,Clinical vertebral fracture,1799,2045,AS cohort entry to exposure,7,0.3422982885
Marketscan,DMARD,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1799,2045,12 months,20,0.97799511
Marketscan,DMARD,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1799,2045,24 months,36,1.760391198
Marketscan,DMARD,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1799,2045,36 months,40,1.95599022
Marketscan,DMARD,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1799,2045,AS cohort entry to exposure,19,0.9290953545
Marketscan,DMARD,PsO/PsA,Psoriasis,1799,2045,12 months,73,3.5696821516
Marketscan,DMARD,PsO/PsA,Psoriasis,1799,2045,24 months,87,4.2542787286
Marketscan,DMARD,PsO/PsA,Psoriasis,1799,2045,36 months,100,4.8899755501
Marketscan,DMARD,PsO/PsA,Psoriasis,1799,2045,AS cohort entry to exposure,49,2.3960880196
Marketscan,DMARD,PsO/PsA,Psoriatic arthritis,1799,2045,12 months,131,6.4058679707
Marketscan,DMARD,PsO/PsA,Psoriatic arthritis,1799,2045,24 months,153,7.4816625917
Marketscan,DMARD,PsO/PsA,Psoriatic arthritis,1799,2045,36 months,157,7.6772616137
Marketscan,DMARD,PsO/PsA,Psoriatic arthritis,1799,2045,AS cohort entry to exposure,87,4.2542787286
Marketscan,DMARD,Uveitis,Uveitis,1799,2045,12 months,139,6.7970660147
Marketscan,DMARD,Uveitis,Uveitis,1799,2045,24 months,166,8.1173594132
Marketscan,DMARD,Uveitis,Uveitis,1799,2045,36 months,175,8.5574572127
Marketscan,DMARD,Uveitis,Uveitis,1799,2045,AS cohort entry to exposure,103,5.0366748166
Marketscan,NSAID or no exposure,Cancer,Hematologic Cancer,8025,10589,12 months,65,0.6138445557
Marketscan,NSAID or no exposure,Cancer,Hematologic Cancer,8025,10589,24 months,76,0.717725942
Marketscan,NSAID or no exposure,Cancer,Hematologic Cancer,8025,10589,36 months,84,0.7932760412
Marketscan,NSAID or no exposure,Cancer,Hematologic Cancer,8025,10589,AS cohort entry to exposure,37,0.3494192086
Marketscan,NSAID or no exposure,Cancer,Non Melanoma Skin Cancer,8025,10589,12 months,85,0.8027198036
Marketscan,NSAID or no exposure,Cancer,Non Melanoma Skin Cancer,8025,10589,24 months,141,1.3315704977
Marketscan,NSAID or no exposure,Cancer,Non Melanoma Skin Cancer,8025,10589,36 months,166,1.5676645576
Marketscan,NSAID or no exposure,Cancer,Non Melanoma Skin Cancer,8025,10589,AS cohort entry to exposure,46,0.4344130702
Marketscan,NSAID or no exposure,Cancer,Solid Cancer,8025,10589,12 months,424,4.0041552555
Marketscan,NSAID or no exposure,Cancer,Solid Cancer,8025,10589,24 months,514,4.854093871
Marketscan,NSAID or no exposure,Cancer,Solid Cancer,8025,10589,36 months,559,5.2790631788
Marketscan,NSAID or no exposure,Cancer,Solid Cancer,8025,10589,AS cohort entry to exposure,200,1.888752479
Marketscan,NSAID or no exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,8025,10589,12 months,141,1.3315704977
Marketscan,NSAID or no exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,8025,10589,24 months,176,1.6621021815
Marketscan,NSAID or no exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,8025,10589,36 months,192,1.8132023798
Marketscan,NSAID or no exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,8025,10589,AS cohort entry to exposure,61,0.5760695061
Marketscan,NSAID or no exposure,Cardiac disease,Conduction Block,8025,10589,12 months,155,1.4637831712
Marketscan,NSAID or no exposure,Cardiac disease,Conduction Block,8025,10589,24 months,208,1.9643025781
Marketscan,NSAID or no exposure,Cardiac disease,Conduction Block,8025,10589,36 months,231,2.1815091132
Marketscan,NSAID or no exposure,Cardiac disease,Conduction Block,8025,10589,AS cohort entry to exposure,79,0.7460572292
Marketscan,NSAID or no exposure,Cardiac disease,Myocardial infarction,8025,10589,12 months,70,0.6610633676
Marketscan,NSAID or no exposure,Cardiac disease,Myocardial infarction,8025,10589,24 months,86,0.812163566
Marketscan,NSAID or no exposure,Cardiac disease,Myocardial infarction,8025,10589,36 months,99,0.9349324771
Marketscan,NSAID or no exposure,Cardiac disease,Myocardial infarction,8025,10589,AS cohort entry to exposure,39,0.3683067334
Marketscan,NSAID or no exposure,Infection,Hospitalized infection,8025,10589,12 months,759,7.1678156578
Marketscan,NSAID or no exposure,Infection,Hospitalized infection,8025,10589,24 months,929,8.7732552649
Marketscan,NSAID or no exposure,Infection,Hospitalized infection,8025,10589,36 months,1008,9.5193124941
Marketscan,NSAID or no exposure,Infection,Hospitalized infection,8025,10589,AS cohort entry to exposure,481,4.542449712
Marketscan,NSAID or no exposure,Infection,Opportunistic infection,8025,10589,12 months,101,0.9538200019
Marketscan,NSAID or no exposure,Infection,Opportunistic infection,8025,10589,24 months,131,1.2371328737
Marketscan,NSAID or no exposure,Infection,Opportunistic infection,8025,10589,36 months,153,1.4448956464
Marketscan,NSAID or no exposure,Infection,Opportunistic infection,8025,10589,AS cohort entry to exposure,38,0.358862971
Marketscan,NSAID or no exposure,Inflammatory bowel disease,Crohn’s Disease,8025,10589,12 months,284,2.6820285202
Marketscan,NSAID or no exposure,Inflammatory bowel disease,Crohn’s Disease,8025,10589,24 months,331,3.1258853527
Marketscan,NSAID or no exposure,Inflammatory bowel disease,Crohn’s Disease,8025,10589,36 months,348,3.2864293134
Marketscan,NSAID or no exposure,Inflammatory bowel disease,Crohn’s Disease,8025,10589,AS cohort entry to exposure,159,1.5015582208
Marketscan,NSAID or no exposure,Inflammatory bowel disease,Ulcerative Colitis,8025,10589,12 months,223,2.1059590141
Marketscan,NSAID or no exposure,Inflammatory bowel disease,Ulcerative Colitis,8025,10589,24 months,249,2.3514968363
Marketscan,NSAID or no exposure,Inflammatory bowel disease,Ulcerative Colitis,8025,10589,36 months,262,2.4742657475
Marketscan,NSAID or no exposure,Inflammatory bowel disease,Ulcerative Colitis,8025,10589,AS cohort entry to exposure,86,0.812163566
Marketscan,NSAID or no exposure,Kidney disease,Amyloidosis,8025,10589,12 months,3,0.0283312872
Marketscan,NSAID or no exposure,Kidney disease,Amyloidosis,8025,10589,24 months,3,0.0283312872
Marketscan,NSAID or no exposure,Kidney disease,Amyloidosis,8025,10589,36 months,3,0.0283312872
Marketscan,NSAID or no exposure,Kidney disease,Amyloidosis,8025,10589,AS cohort entry to exposure,0,0
Marketscan,NSAID or no exposure,Kidney disease,IgA nephropathy,8025,10589,12 months,10,0.0944376239
Marketscan,NSAID or no exposure,Kidney disease,IgA nephropathy,8025,10589,24 months,11,0.1038813863
Marketscan,NSAID or no exposure,Kidney disease,IgA nephropathy,8025,10589,36 months,12,0.1133251487
Marketscan,NSAID or no exposure,Kidney disease,IgA nephropathy,8025,10589,AS cohort entry to exposure,3,0.0283312872
Marketscan,NSAID or no exposure,Kidney disease,Nephrotic syndrome,8025,10589,12 months,2,0.0188875248
Marketscan,NSAID or no exposure,Kidney disease,Nephrotic syndrome,8025,10589,24 months,4,0.0377750496
Marketscan,NSAID or no exposure,Kidney disease,Nephrotic syndrome,8025,10589,36 months,5,0.047218812
Marketscan,NSAID or no exposure,Kidney disease,Nephrotic syndrome,8025,10589,AS cohort entry to exposure,0,0
Marketscan,NSAID or no exposure,Lung disease,Apical Pulmonary fibrosis,8025,10589,12 months,2,0.0188875248
Marketscan,NSAID or no exposure,Lung disease,Apical Pulmonary fibrosis,8025,10589,24 months,2,0.0188875248
Marketscan,NSAID or no exposure,Lung disease,Apical Pulmonary fibrosis,8025,10589,36 months,2,0.0188875248
Marketscan,NSAID or no exposure,Lung disease,Apical Pulmonary fibrosis,8025,10589,AS cohort entry to exposure,0,0
Marketscan,NSAID or no exposure,Lung disease,Interstitial lung disease,8025,10589,12 months,11,0.1038813863
Marketscan,NSAID or no exposure,Lung disease,Interstitial lung disease,8025,10589,24 months,13,0.1227689111
Marketscan,NSAID or no exposure,Lung disease,Interstitial lung disease,8025,10589,36 months,14,0.1322126735
Marketscan,NSAID or no exposure,Lung disease,Interstitial lung disease,8025,10589,AS cohort entry to exposure,6,0.0566625744
Marketscan,NSAID or no exposure,Lung disease,Restrictive lung disease ,8025,10589,12 months,141,1.3315704977
Marketscan,NSAID or no exposure,Lung disease,Restrictive lung disease ,8025,10589,24 months,175,1.6526584191
Marketscan,NSAID or no exposure,Lung disease,Restrictive lung disease ,8025,10589,36 months,201,1.8981962414
Marketscan,NSAID or no exposure,Lung disease,Restrictive lung disease ,8025,10589,AS cohort entry to exposure,67,0.6327320805
Marketscan,NSAID or no exposure,Neurological Disease,Cauda Equina syndrome,8025,10589,12 months,4,0.0377750496
Marketscan,NSAID or no exposure,Neurological Disease,Cauda Equina syndrome,8025,10589,24 months,5,0.047218812
Marketscan,NSAID or no exposure,Neurological Disease,Cauda Equina syndrome,8025,10589,36 months,5,0.047218812
Marketscan,NSAID or no exposure,Neurological Disease,Cauda Equina syndrome,8025,10589,AS cohort entry to exposure,1,0.0094437624
Marketscan,NSAID or no exposure,Neurological Disease,Spinal Cord compression,8025,10589,12 months,45,0.4249693078
Marketscan,NSAID or no exposure,Neurological Disease,Spinal Cord compression,8025,10589,24 months,61,0.5760695061
Marketscan,NSAID or no exposure,Neurological Disease,Spinal Cord compression,8025,10589,36 months,64,0.6044007933
Marketscan,NSAID or no exposure,Neurological Disease,Spinal Cord compression,8025,10589,AS cohort entry to exposure,22,0.2077627727
Marketscan,NSAID or no exposure,Osteoporotic fracture,Clinical vertebral fracture,8025,10589,12 months,287,2.7103598073
Marketscan,NSAID or no exposure,Osteoporotic fracture,Clinical vertebral fracture,8025,10589,24 months,326,3.0786665407
Marketscan,NSAID or no exposure,Osteoporotic fracture,Clinical vertebral fracture,8025,10589,36 months,346,3.2675417886
Marketscan,NSAID or no exposure,Osteoporotic fracture,Clinical vertebral fracture,8025,10589,AS cohort entry to exposure,169,1.5959958447
Marketscan,NSAID or no exposure,Osteoporotic fracture,Non-vertebral osteoporotic fracture,8025,10589,12 months,219,2.0681839645
Marketscan,NSAID or no exposure,Osteoporotic fracture,Non-vertebral osteoporotic fracture,8025,10589,24 months,288,2.7198035697
Marketscan,NSAID or no exposure,Osteoporotic fracture,Non-vertebral osteoporotic fracture,8025,10589,36 months,322,3.0408914912
Marketscan,NSAID or no exposure,Osteoporotic fracture,Non-vertebral osteoporotic fracture,8025,10589,AS cohort entry to exposure,132,1.2465766361
Marketscan,NSAID or no exposure,PsO/PsA,Psoriasis,8025,10589,12 months,219,2.0681839645
Marketscan,NSAID or no exposure,PsO/PsA,Psoriasis,8025,10589,24 months,272,2.5687033714
Marketscan,NSAID or no exposure,PsO/PsA,Psoriasis,8025,10589,36 months,311,2.9370101048
Marketscan,NSAID or no exposure,PsO/PsA,Psoriasis,8025,10589,AS cohort entry to exposure,109,1.029370101
Marketscan,NSAID or no exposure,PsO/PsA,Psoriatic arthritis,8025,10589,12 months,258,2.4364906979
Marketscan,NSAID or no exposure,PsO/PsA,Psoriatic arthritis,8025,10589,24 months,312,2.9464538672
Marketscan,NSAID or no exposure,PsO/PsA,Psoriatic arthritis,8025,10589,36 months,340,3.2108792143
Marketscan,NSAID or no exposure,PsO/PsA,Psoriatic arthritis,8025,10589,AS cohort entry to exposure,147,1.3882330721
Marketscan,NSAID or no exposure,Uveitis,Uveitis,8025,10589,12 months,774,7.3094720937
Marketscan,NSAID or no exposure,Uveitis,Uveitis,8025,10589,24 months,901,8.5088299178
Marketscan,NSAID or no exposure,Uveitis,Uveitis,8025,10589,36 months,951,8.9810180376
Marketscan,NSAID or no exposure,Uveitis,Uveitis,8025,10589,AS cohort entry to exposure,364,3.4375295118
Marketscan,TNF,Cancer,Hematologic Cancer,4797,5779,12 months,8,0.1384322547
Marketscan,TNF,Cancer,Hematologic Cancer,4797,5779,24 months,16,0.2768645094
Marketscan,TNF,Cancer,Hematologic Cancer,4797,5779,36 months,16,0.2768645094
Marketscan,TNF,Cancer,Hematologic Cancer,4797,5779,AS cohort entry to exposure,5,0.0865201592
Marketscan,TNF,Cancer,Non Melanoma Skin Cancer,4797,5779,12 months,30,0.5191209552
Marketscan,TNF,Cancer,Non Melanoma Skin Cancer,4797,5779,24 months,59,1.0209378785
Marketscan,TNF,Cancer,Non Melanoma Skin Cancer,4797,5779,36 months,72,1.2458902924
Marketscan,TNF,Cancer,Non Melanoma Skin Cancer,4797,5779,AS cohort entry to exposure,26,0.4499048278
Marketscan,TNF,Cancer,Solid Cancer,4797,5779,12 months,103,1.7823152795
Marketscan,TNF,Cancer,Solid Cancer,4797,5779,24 months,145,2.5090846167
Marketscan,TNF,Cancer,Solid Cancer,4797,5779,36 months,157,2.7167329988
Marketscan,TNF,Cancer,Solid Cancer,4797,5779,AS cohort entry to exposure,80,1.3843225472
Marketscan,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,4797,5779,12 months,47,0.8132894965
Marketscan,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,4797,5779,24 months,59,1.0209378785
Marketscan,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,4797,5779,36 months,70,1.2112822288
Marketscan,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,4797,5779,AS cohort entry to exposure,37,0.6402491781
Marketscan,TNF,Cardiac disease,Conduction Block,4797,5779,12 months,41,0.7094653054
Marketscan,TNF,Cardiac disease,Conduction Block,4797,5779,24 months,60,1.0382419104
Marketscan,TNF,Cardiac disease,Conduction Block,4797,5779,36 months,71,1.2285862606
Marketscan,TNF,Cardiac disease,Conduction Block,4797,5779,AS cohort entry to exposure,30,0.5191209552
Marketscan,TNF,Cardiac disease,Myocardial infarction,4797,5779,12 months,11,0.1903443502
Marketscan,TNF,Cardiac disease,Myocardial infarction,4797,5779,24 months,20,0.3460806368
Marketscan,TNF,Cardiac disease,Myocardial infarction,4797,5779,36 months,21,0.3633846686
Marketscan,TNF,Cardiac disease,Myocardial infarction,4797,5779,AS cohort entry to exposure,16,0.2768645094
Marketscan,TNF,Infection,Hospitalized infection,4797,5779,12 months,204,3.5300224952
Marketscan,TNF,Infection,Hospitalized infection,4797,5779,24 months,293,5.0700813289
Marketscan,TNF,Infection,Hospitalized infection,4797,5779,36 months,332,5.7449385707
Marketscan,TNF,Infection,Hospitalized infection,4797,5779,AS cohort entry to exposure,194,3.3569821768
Marketscan,TNF,Infection,Opportunistic infection,4797,5779,12 months,68,1.1766741651
Marketscan,TNF,Infection,Opportunistic infection,4797,5779,24 months,91,1.5746668974
Marketscan,TNF,Infection,Opportunistic infection,4797,5779,36 months,101,1.7477072158
Marketscan,TNF,Infection,Opportunistic infection,4797,5779,AS cohort entry to exposure,59,1.0209378785
Marketscan,TNF,Inflammatory bowel disease,Crohn’s Disease,4797,5779,12 months,320,5.5372901886
Marketscan,TNF,Inflammatory bowel disease,Crohn’s Disease,4797,5779,24 months,362,6.2640595259
Marketscan,TNF,Inflammatory bowel disease,Crohn’s Disease,4797,5779,36 months,373,6.4544038761
Marketscan,TNF,Inflammatory bowel disease,Crohn’s Disease,4797,5779,AS cohort entry to exposure,258,4.4644402146
Marketscan,TNF,Inflammatory bowel disease,Ulcerative Colitis,4797,5779,12 months,209,3.6165426544
Marketscan,TNF,Inflammatory bowel disease,Ulcerative Colitis,4797,5779,24 months,237,4.1010555459
Marketscan,TNF,Inflammatory bowel disease,Ulcerative Colitis,4797,5779,36 months,254,4.3952240872
Marketscan,TNF,Inflammatory bowel disease,Ulcerative Colitis,4797,5779,AS cohort entry to exposure,150,2.5956047759
Marketscan,TNF,Kidney disease,Amyloidosis,4797,5779,12 months,2,0.0346080637
Marketscan,TNF,Kidney disease,Amyloidosis,4797,5779,24 months,4,0.0692161274
Marketscan,TNF,Kidney disease,Amyloidosis,4797,5779,36 months,4,0.0692161274
Marketscan,TNF,Kidney disease,Amyloidosis,4797,5779,AS cohort entry to exposure,0,0
Marketscan,TNF,Kidney disease,IgA nephropathy,4797,5779,12 months,7,0.1211282229
Marketscan,TNF,Kidney disease,IgA nephropathy,4797,5779,24 months,9,0.1557362866
Marketscan,TNF,Kidney disease,IgA nephropathy,4797,5779,36 months,10,0.1730403184
Marketscan,TNF,Kidney disease,IgA nephropathy,4797,5779,AS cohort entry to exposure,5,0.0865201592
Marketscan,TNF,Kidney disease,Nephrotic syndrome,4797,5779,12 months,4,0.0692161274
Marketscan,TNF,Kidney disease,Nephrotic syndrome,4797,5779,24 months,6,0.103824191
Marketscan,TNF,Kidney disease,Nephrotic syndrome,4797,5779,36 months,6,0.103824191
Marketscan,TNF,Kidney disease,Nephrotic syndrome,4797,5779,AS cohort entry to exposure,3,0.0519120955
Marketscan,TNF,Lung disease,Apical Pulmonary fibrosis,4797,5779,12 months,1,0.0173040318
Marketscan,TNF,Lung disease,Apical Pulmonary fibrosis,4797,5779,24 months,1,0.0173040318
Marketscan,TNF,Lung disease,Apical Pulmonary fibrosis,4797,5779,36 months,1,0.0173040318
Marketscan,TNF,Lung disease,Apical Pulmonary fibrosis,4797,5779,AS cohort entry to exposure,0,0
Marketscan,TNF,Lung disease,Interstitial lung disease,4797,5779,12 months,6,0.103824191
Marketscan,TNF,Lung disease,Interstitial lung disease,4797,5779,24 months,6,0.103824191
Marketscan,TNF,Lung disease,Interstitial lung disease,4797,5779,36 months,6,0.103824191
Marketscan,TNF,Lung disease,Interstitial lung disease,4797,5779,AS cohort entry to exposure,4,0.0692161274
Marketscan,TNF,Lung disease,Restrictive lung disease ,4797,5779,12 months,50,0.865201592
Marketscan,TNF,Lung disease,Restrictive lung disease ,4797,5779,24 months,72,1.2458902924
Marketscan,TNF,Lung disease,Restrictive lung disease ,4797,5779,36 months,82,1.4189306108
Marketscan,TNF,Lung disease,Restrictive lung disease ,4797,5779,AS cohort entry to exposure,34,0.5883370825
Marketscan,TNF,Neurological Disease,Cauda Equina syndrome,4797,5779,12 months,0,0
Marketscan,TNF,Neurological Disease,Cauda Equina syndrome,4797,5779,24 months,1,0.0173040318
Marketscan,TNF,Neurological Disease,Cauda Equina syndrome,4797,5779,36 months,2,0.0346080637
Marketscan,TNF,Neurological Disease,Cauda Equina syndrome,4797,5779,AS cohort entry to exposure,0,0
Marketscan,TNF,Neurological Disease,Spinal Cord compression,4797,5779,12 months,9,0.1557362866
Marketscan,TNF,Neurological Disease,Spinal Cord compression,4797,5779,24 months,14,0.2422564458
Marketscan,TNF,Neurological Disease,Spinal Cord compression,4797,5779,36 months,25,0.432600796
Marketscan,TNF,Neurological Disease,Spinal Cord compression,4797,5779,AS cohort entry to exposure,3,0.0519120955
Marketscan,TNF,Osteoporotic fracture,Clinical vertebral fracture,4797,5779,12 months,33,0.5710330507
Marketscan,TNF,Osteoporotic fracture,Clinical vertebral fracture,4797,5779,24 months,46,0.7959854646
Marketscan,TNF,Osteoporotic fracture,Clinical vertebral fracture,4797,5779,36 months,52,0.8998096556
Marketscan,TNF,Osteoporotic fracture,Clinical vertebral fracture,4797,5779,AS cohort entry to exposure,24,0.4152967641
Marketscan,TNF,Osteoporotic fracture,Non-vertebral osteoporotic fracture,4797,5779,12 months,58,1.0036338467
Marketscan,TNF,Osteoporotic fracture,Non-vertebral osteoporotic fracture,4797,5779,24 months,98,1.6957951203
Marketscan,TNF,Osteoporotic fracture,Non-vertebral osteoporotic fracture,4797,5779,36 months,117,2.0245717252
Marketscan,TNF,Osteoporotic fracture,Non-vertebral osteoporotic fracture,4797,5779,AS cohort entry to exposure,50,0.865201592
Marketscan,TNF,PsO/PsA,Psoriasis,4797,5779,12 months,252,4.3606160235
Marketscan,TNF,PsO/PsA,Psoriasis,4797,5779,24 months,322,5.5718982523
Marketscan,TNF,PsO/PsA,Psoriasis,4797,5779,36 months,361,6.246755494
Marketscan,TNF,PsO/PsA,Psoriasis,4797,5779,AS cohort entry to exposure,179,3.0974216993
Marketscan,TNF,PsO/PsA,Psoriatic arthritis,4797,5779,12 months,409,7.0773490223
Marketscan,TNF,PsO/PsA,Psoriatic arthritis,4797,5779,24 months,476,8.2367191556
Marketscan,TNF,PsO/PsA,Psoriatic arthritis,4797,5779,36 months,496,8.5827997924
Marketscan,TNF,PsO/PsA,Psoriatic arthritis,4797,5779,AS cohort entry to exposure,334,5.7795466344
Marketscan,TNF,Uveitis,Uveitis,4797,5779,12 months,448,7.7522062641
Marketscan,TNF,Uveitis,Uveitis,4797,5779,24 months,517,8.946184461
Marketscan,TNF,Uveitis,Uveitis,4797,5779,36 months,553,9.5691296072
Marketscan,TNF,Uveitis,Uveitis,4797,5779,AS cohort entry to exposure,375,6.4890119398
Medicare,DMARD,Cancer,Hematologic Cancer,4231,5193,12 months,85,1.6368187945
Medicare,DMARD,Cancer,Hematologic Cancer,4231,5193,24 months,109,2.0989793953
Medicare,DMARD,Cancer,Hematologic Cancer,4231,5193,36 months,118,2.2722896206
Medicare,DMARD,Cancer,Hematologic Cancer,4231,5193,AS cohort entry to exposure,72,1.3864818024
Medicare,DMARD,Cancer,Non Melanoma Skin Cancer,4231,5193,12 months,67,1.2901983439
Medicare,DMARD,Cancer,Non Melanoma Skin Cancer,4231,5193,24 months,118,2.2722896206
Medicare,DMARD,Cancer,Non Melanoma Skin Cancer,4231,5193,36 months,159,3.0618139804
Medicare,DMARD,Cancer,Non Melanoma Skin Cancer,4231,5193,AS cohort entry to exposure,55,1.0591180435
Medicare,DMARD,Cancer,Solid Cancer,4231,5193,12 months,399,7.6834199884
Medicare,DMARD,Cancer,Solid Cancer,4231,5193,24 months,515,9.9171962257
Medicare,DMARD,Cancer,Solid Cancer,4231,5193,36 months,583,11.226651261
Medicare,DMARD,Cancer,Solid Cancer,4231,5193,AS cohort entry to exposure,340,6.5472751781
Medicare,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,4231,5193,12 months,192,3.6972848065
Medicare,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,4231,5193,24 months,288,5.5459272097
Medicare,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,4231,5193,36 months,336,6.4702484113
Medicare,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,4231,5193,AS cohort entry to exposure,161,3.1003273638
Medicare,DMARD,Cardiac disease,Conduction Block,4231,5193,12 months,155,2.9847872136
Medicare,DMARD,Cardiac disease,Conduction Block,4231,5193,24 months,228,4.3905257077
Medicare,DMARD,Cardiac disease,Conduction Block,4231,5193,36 months,280,5.3918736761
Medicare,DMARD,Cardiac disease,Conduction Block,4231,5193,AS cohort entry to exposure,130,2.503369921
Medicare,DMARD,Cardiac disease,Myocardial infarction,4231,5193,12 months,47,0.9050645099
Medicare,DMARD,Cardiac disease,Myocardial infarction,4231,5193,24 months,86,1.6560754862
Medicare,DMARD,Cardiac disease,Myocardial infarction,4231,5193,36 months,125,2.4070864625
Medicare,DMARD,Cardiac disease,Myocardial infarction,4231,5193,AS cohort entry to exposure,54,1.0398613518
Medicare,DMARD,Infection,Hospitalized infection,4231,5193,12 months,717,13.807047949
Medicare,DMARD,Infection,Hospitalized infection,4231,5193,24 months,1058,20.373579819
Medicare,DMARD,Infection,Hospitalized infection,4231,5193,36 months,1292,24.879645677
Medicare,DMARD,Infection,Hospitalized infection,4231,5193,AS cohort entry to exposure,825,15.886770653
Medicare,DMARD,Infection,Opportunistic infection,4231,5193,12 months,144,2.7729636049
Medicare,DMARD,Infection,Opportunistic infection,4231,5193,24 months,212,4.0824186405
Medicare,DMARD,Infection,Opportunistic infection,4231,5193,36 months,251,4.8334296168
Medicare,DMARD,Infection,Opportunistic infection,4231,5193,AS cohort entry to exposure,160,3.0810706721
Medicare,DMARD,Inflammatory bowel disease,Crohn’s Disease,4231,5193,12 months,342,6.5857885615
Medicare,DMARD,Inflammatory bowel disease,Crohn’s Disease,4231,5193,24 months,371,7.1442326208
Medicare,DMARD,Inflammatory bowel disease,Crohn’s Disease,4231,5193,36 months,386,7.4330829963
Medicare,DMARD,Inflammatory bowel disease,Crohn’s Disease,4231,5193,AS cohort entry to exposure,320,6.1621413441
Medicare,DMARD,Inflammatory bowel disease,Ulcerative Colitis,4231,5193,12 months,187,3.601001348
Medicare,DMARD,Inflammatory bowel disease,Ulcerative Colitis,4231,5193,24 months,222,4.2749855575
Medicare,DMARD,Inflammatory bowel disease,Ulcerative Colitis,4231,5193,36 months,239,4.6023493164
Medicare,DMARD,Inflammatory bowel disease,Ulcerative Colitis,4231,5193,AS cohort entry to exposure,199,3.8320816484
Medicare,DMARD,Kidney disease,Amyloidosis,4231,5193,12 months,2,0.0385133834
Medicare,DMARD,Kidney disease,Amyloidosis,4231,5193,24 months,2,0.0385133834
Medicare,DMARD,Kidney disease,Amyloidosis,4231,5193,36 months,2,0.0385133834
Medicare,DMARD,Kidney disease,Amyloidosis,4231,5193,AS cohort entry to exposure,2,0.0385133834
Medicare,DMARD,Kidney disease,IgA nephropathy,4231,5193,12 months,10,0.192566917
Medicare,DMARD,Kidney disease,IgA nephropathy,4231,5193,24 months,16,0.3081070672
Medicare,DMARD,Kidney disease,IgA nephropathy,4231,5193,36 months,20,0.385133834
Medicare,DMARD,Kidney disease,IgA nephropathy,4231,5193,AS cohort entry to exposure,11,0.2118236087
Medicare,DMARD,Kidney disease,Nephrotic syndrome,4231,5193,12 months,12,0.2310803004
Medicare,DMARD,Kidney disease,Nephrotic syndrome,4231,5193,24 months,19,0.3658771423
Medicare,DMARD,Kidney disease,Nephrotic syndrome,4231,5193,36 months,20,0.385133834
Medicare,DMARD,Kidney disease,Nephrotic syndrome,4231,5193,AS cohort entry to exposure,8,0.1540535336
Medicare,DMARD,Lung disease,Apical Pulmonary fibrosis,4231,5193,12 months,2,0.0385133834
Medicare,DMARD,Lung disease,Apical Pulmonary fibrosis,4231,5193,24 months,2,0.0385133834
Medicare,DMARD,Lung disease,Apical Pulmonary fibrosis,4231,5193,36 months,2,0.0385133834
Medicare,DMARD,Lung disease,Apical Pulmonary fibrosis,4231,5193,AS cohort entry to exposure,2,0.0385133834
Medicare,DMARD,Lung disease,Interstitial lung disease,4231,5193,12 months,56,1.0783747352
Medicare,DMARD,Lung disease,Interstitial lung disease,4231,5193,24 months,85,1.6368187945
Medicare,DMARD,Lung disease,Interstitial lung disease,4231,5193,36 months,101,1.9449258617
Medicare,DMARD,Lung disease,Interstitial lung disease,4231,5193,AS cohort entry to exposure,58,1.1168881186
Medicare,DMARD,Lung disease,Restrictive lung disease ,4231,5193,12 months,176,3.3891777393
Medicare,DMARD,Lung disease,Restrictive lung disease ,4231,5193,24 months,252,4.8526863085
Medicare,DMARD,Lung disease,Restrictive lung disease ,4231,5193,36 months,311,5.9888311188
Medicare,DMARD,Lung disease,Restrictive lung disease ,4231,5193,AS cohort entry to exposure,194,3.7357981899
Medicare,DMARD,Neurological Disease,Cauda Equina syndrome,4231,5193,12 months,1,0.0192566917
Medicare,DMARD,Neurological Disease,Cauda Equina syndrome,4231,5193,24 months,1,0.0192566917
Medicare,DMARD,Neurological Disease,Cauda Equina syndrome,4231,5193,36 months,3,0.0577700751
Medicare,DMARD,Neurological Disease,Cauda Equina syndrome,4231,5193,AS cohort entry to exposure,7,0.1347968419
Medicare,DMARD,Neurological Disease,Spinal Cord compression,4231,5193,12 months,21,0.4043905257
Medicare,DMARD,Neurological Disease,Spinal Cord compression,4231,5193,24 months,32,0.6162141344
Medicare,DMARD,Neurological Disease,Spinal Cord compression,4231,5193,36 months,34,0.6547275178
Medicare,DMARD,Neurological Disease,Spinal Cord compression,4231,5193,AS cohort entry to exposure,30,0.577700751
Medicare,DMARD,Osteoporotic fracture,Clinical vertebral fracture,4231,5193,12 months,139,2.6766801464
Medicare,DMARD,Osteoporotic fracture,Clinical vertebral fracture,4231,5193,24 months,223,4.2942422492
Medicare,DMARD,Osteoporotic fracture,Clinical vertebral fracture,4231,5193,36 months,279,5.3726169844
Medicare,DMARD,Osteoporotic fracture,Clinical vertebral fracture,4231,5193,AS cohort entry to exposure,184,3.5432312729
Medicare,DMARD,Osteoporotic fracture,Non-vertebral osteoporotic fracture,4231,5193,12 months,157,3.023300597
Medicare,DMARD,Osteoporotic fracture,Non-vertebral osteoporotic fracture,4231,5193,24 months,279,5.3726169844
Medicare,DMARD,Osteoporotic fracture,Non-vertebral osteoporotic fracture,4231,5193,36 months,358,6.8938956287
Medicare,DMARD,Osteoporotic fracture,Non-vertebral osteoporotic fracture,4231,5193,AS cohort entry to exposure,242,4.6601193915
Medicare,DMARD,PsO/PsA,Psoriasis,4231,5193,12 months,251,4.8334296168
Medicare,DMARD,PsO/PsA,Psoriasis,4231,5193,24 months,331,6.3739649528
Medicare,DMARD,PsO/PsA,Psoriasis,4231,5193,36 months,386,7.4330829963
Medicare,DMARD,PsO/PsA,Psoriasis,4231,5193,AS cohort entry to exposure,251,4.8334296168
Medicare,DMARD,PsO/PsA,Psoriatic arthritis,4231,5193,12 months,422,8.1263238976
Medicare,DMARD,PsO/PsA,Psoriatic arthritis,4231,5193,24 months,477,9.1854419411
Medicare,DMARD,PsO/PsA,Psoriatic arthritis,4231,5193,36 months,514,9.897939534
Medicare,DMARD,PsO/PsA,Psoriatic arthritis,4231,5193,AS cohort entry to exposure,394,7.5871365299
Medicare,DMARD,Uveitis,Uveitis,4231,5193,12 months,259,4.9874831504
Medicare,DMARD,Uveitis,Uveitis,4231,5193,24 months,319,6.1428846524
Medicare,DMARD,Uveitis,Uveitis,4231,5193,36 months,361,6.9516657038
Medicare,DMARD,Uveitis,Uveitis,4231,5193,AS cohort entry to exposure,292,5.6229539765
Medicare,NSAID or no exposure,Cancer,Hematologic Cancer,17983,26122,12 months,455,1.7418268126
Medicare,NSAID or no exposure,Cancer,Hematologic Cancer,17983,26122,24 months,524,2.0059719776
Medicare,NSAID or no exposure,Cancer,Hematologic Cancer,17983,26122,36 months,584,2.2356634255
Medicare,NSAID or no exposure,Cancer,Hematologic Cancer,17983,26122,AS cohort entry to exposure,265,1.0144705612
Medicare,NSAID or no exposure,Cancer,Non Melanoma Skin Cancer,17983,26122,12 months,575,2.2012097083
Medicare,NSAID or no exposure,Cancer,Non Melanoma Skin Cancer,17983,26122,24 months,885,3.3879488554
Medicare,NSAID or no exposure,Cancer,Non Melanoma Skin Cancer,17983,26122,36 months,1071,4.0999923436
Medicare,NSAID or no exposure,Cancer,Non Melanoma Skin Cancer,17983,26122,AS cohort entry to exposure,243,0.9302503637
Medicare,NSAID or no exposure,Cancer,Solid Cancer,17983,26122,12 months,2753,10.539009264
Medicare,NSAID or no exposure,Cancer,Solid Cancer,17983,26122,24 months,3332,12.755531736
Medicare,NSAID or no exposure,Cancer,Solid Cancer,17983,26122,36 months,3655,13.992037363
Medicare,NSAID or no exposure,Cancer,Solid Cancer,17983,26122,AS cohort entry to exposure,1419,5.432202741
Medicare,NSAID or no exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,17983,26122,12 months,1294,4.9536788914
Medicare,NSAID or no exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,17983,26122,24 months,1663,6.3662812955
Medicare,NSAID or no exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,17983,26122,36 months,1880,7.1969986984
Medicare,NSAID or no exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,17983,26122,AS cohort entry to exposure,697,2.6682489855
Medicare,NSAID or no exposure,Cardiac disease,Conduction Block,17983,26122,12 months,1204,4.6091417196
Medicare,NSAID or no exposure,Cardiac disease,Conduction Block,17983,26122,24 months,1652,6.3241711967
Medicare,NSAID or no exposure,Cardiac disease,Conduction Block,17983,26122,36 months,1946,7.449659291
Medicare,NSAID or no exposure,Cardiac disease,Conduction Block,17983,26122,AS cohort entry to exposure,737,2.8213766174
Medicare,NSAID or no exposure,Cardiac disease,Myocardial infarction,17983,26122,12 months,438,1.6767475691
Medicare,NSAID or no exposure,Cardiac disease,Myocardial infarction,17983,26122,24 months,649,2.4844958273
Medicare,NSAID or no exposure,Cardiac disease,Myocardial infarction,17983,26122,36 months,786,3.0089579665
Medicare,NSAID or no exposure,Cardiac disease,Myocardial infarction,17983,26122,AS cohort entry to exposure,261,0.999157798
Medicare,NSAID or no exposure,Infection,Hospitalized infection,17983,26122,12 months,4968,19.01845188
Medicare,NSAID or no exposure,Infection,Hospitalized infection,17983,26122,24 months,6453,24.703315213
Medicare,NSAID or no exposure,Infection,Hospitalized infection,17983,26122,36 months,7305,27.964933772
Medicare,NSAID or no exposure,Infection,Hospitalized infection,17983,26122,AS cohort entry to exposure,3499,13.394839599
Medicare,NSAID or no exposure,Infection,Opportunistic infection,17983,26122,12 months,592,2.2662889518
Medicare,NSAID or no exposure,Infection,Opportunistic infection,17983,26122,24 months,890,3.4070898094
Medicare,NSAID or no exposure,Infection,Opportunistic infection,17983,26122,36 months,1108,4.2416354031
Medicare,NSAID or no exposure,Infection,Opportunistic infection,17983,26122,AS cohort entry to exposure,416,1.5925273716
Medicare,NSAID or no exposure,Inflammatory bowel disease,Crohn’s Disease,17983,26122,12 months,1023,3.9162391854
Medicare,NSAID or no exposure,Inflammatory bowel disease,Crohn’s Disease,17983,26122,24 months,1152,4.4100757982
Medicare,NSAID or no exposure,Inflammatory bowel disease,Crohn’s Disease,17983,26122,36 months,1216,4.6550800092
Medicare,NSAID or no exposure,Inflammatory bowel disease,Crohn’s Disease,17983,26122,AS cohort entry to exposure,686,2.6261388868
Medicare,NSAID or no exposure,Inflammatory bowel disease,Ulcerative Colitis,17983,26122,12 months,551,2.1093331292
Medicare,NSAID or no exposure,Inflammatory bowel disease,Ulcerative Colitis,17983,26122,24 months,692,2.6491080315
Medicare,NSAID or no exposure,Inflammatory bowel disease,Ulcerative Colitis,17983,26122,36 months,792,3.0319271112
Medicare,NSAID or no exposure,Inflammatory bowel disease,Ulcerative Colitis,17983,26122,AS cohort entry to exposure,385,1.4738534569
Medicare,NSAID or no exposure,Kidney disease,Amyloidosis,17983,26122,12 months,19,0.0727356251
Medicare,NSAID or no exposure,Kidney disease,Amyloidosis,17983,26122,24 months,20,0.0765638159
Medicare,NSAID or no exposure,Kidney disease,Amyloidosis,17983,26122,36 months,24,0.0918765791
Medicare,NSAID or no exposure,Kidney disease,Amyloidosis,17983,26122,AS cohort entry to exposure,11,0.0421100988
Medicare,NSAID or no exposure,Kidney disease,IgA nephropathy,17983,26122,12 months,49,0.1875813491
Medicare,NSAID or no exposure,Kidney disease,IgA nephropathy,17983,26122,24 months,71,0.2718015466
Medicare,NSAID or no exposure,Kidney disease,IgA nephropathy,17983,26122,36 months,90,0.3445371717
Medicare,NSAID or no exposure,Kidney disease,IgA nephropathy,17983,26122,AS cohort entry to exposure,46,0.1760967767
Medicare,NSAID or no exposure,Kidney disease,Nephrotic syndrome,17983,26122,12 months,43,0.1646122043
Medicare,NSAID or no exposure,Kidney disease,Nephrotic syndrome,17983,26122,24 months,52,0.1990659214
Medicare,NSAID or no exposure,Kidney disease,Nephrotic syndrome,17983,26122,36 months,56,0.2143786846
Medicare,NSAID or no exposure,Kidney disease,Nephrotic syndrome,17983,26122,AS cohort entry to exposure,18,0.0689074343
Medicare,NSAID or no exposure,Lung disease,Apical Pulmonary fibrosis,17983,26122,12 months,5,0.019140954
Medicare,NSAID or no exposure,Lung disease,Apical Pulmonary fibrosis,17983,26122,24 months,6,0.0229691448
Medicare,NSAID or no exposure,Lung disease,Apical Pulmonary fibrosis,17983,26122,36 months,6,0.0229691448
Medicare,NSAID or no exposure,Lung disease,Apical Pulmonary fibrosis,17983,26122,AS cohort entry to exposure,4,0.0153127632
Medicare,NSAID or no exposure,Lung disease,Interstitial lung disease,17983,26122,12 months,162,0.6201669091
Medicare,NSAID or no exposure,Lung disease,Interstitial lung disease,17983,26122,24 months,219,0.8383737845
Medicare,NSAID or no exposure,Lung disease,Interstitial lung disease,17983,26122,36 months,254,0.9723604624
Medicare,NSAID or no exposure,Lung disease,Interstitial lung disease,17983,26122,AS cohort entry to exposure,126,0.4823520404
Medicare,NSAID or no exposure,Lung disease,Restrictive lung disease ,17983,26122,12 months,808,3.093178164
Medicare,NSAID or no exposure,Lung disease,Restrictive lung disease ,17983,26122,24 months,1192,4.5632034301
Medicare,NSAID or no exposure,Lung disease,Restrictive lung disease ,17983,26122,36 months,1437,5.5011101753
Medicare,NSAID or no exposure,Lung disease,Restrictive lung disease ,17983,26122,AS cohort entry to exposure,561,2.1476150371
Medicare,NSAID or no exposure,Neurological Disease,Cauda Equina syndrome,17983,26122,12 months,45,0.1722685859
Medicare,NSAID or no exposure,Neurological Disease,Cauda Equina syndrome,17983,26122,24 months,57,0.2182068754
Medicare,NSAID or no exposure,Neurological Disease,Cauda Equina syndrome,17983,26122,36 months,60,0.2296914478
Medicare,NSAID or no exposure,Neurological Disease,Cauda Equina syndrome,17983,26122,AS cohort entry to exposure,29,0.1110175331
Medicare,NSAID or no exposure,Neurological Disease,Spinal Cord compression,17983,26122,12 months,195,0.7464972054
Medicare,NSAID or no exposure,Neurological Disease,Spinal Cord compression,17983,26122,24 months,239,0.9149376005
Medicare,NSAID or no exposure,Neurological Disease,Spinal Cord compression,17983,26122,36 months,264,1.0106423704
Medicare,NSAID or no exposure,Neurological Disease,Spinal Cord compression,17983,26122,AS cohort entry to exposure,115,0.4402419417
Medicare,NSAID or no exposure,Osteoporotic fracture,Clinical vertebral fracture,17983,26122,12 months,1845,7.0630120205
Medicare,NSAID or no exposure,Osteoporotic fracture,Clinical vertebral fracture,17983,26122,24 months,2267,8.6785085369
Medicare,NSAID or no exposure,Osteoporotic fracture,Clinical vertebral fracture,17983,26122,36 months,2471,9.4594594595
Medicare,NSAID or no exposure,Osteoporotic fracture,Clinical vertebral fracture,17983,26122,AS cohort entry to exposure,1182,4.5249215221
Medicare,NSAID or no exposure,Osteoporotic fracture,Non-vertebral osteoporotic fracture,17983,26122,12 months,1215,4.6512518184
Medicare,NSAID or no exposure,Osteoporotic fracture,Non-vertebral osteoporotic fracture,17983,26122,24 months,1745,6.6801929408
Medicare,NSAID or no exposure,Osteoporotic fracture,Non-vertebral osteoporotic fracture,17983,26122,36 months,2112,8.0851389633
Medicare,NSAID or no exposure,Osteoporotic fracture,Non-vertebral osteoporotic fracture,17983,26122,AS cohort entry to exposure,1005,3.847331751
Medicare,NSAID or no exposure,PsO/PsA,Psoriasis,17983,26122,12 months,819,3.1352882628
Medicare,NSAID or no exposure,PsO/PsA,Psoriasis,17983,26122,24 months,1076,4.1191332976
Medicare,NSAID or no exposure,PsO/PsA,Psoriasis,17983,26122,36 months,1207,4.620626292
Medicare,NSAID or no exposure,PsO/PsA,Psoriasis,17983,26122,AS cohort entry to exposure,581,2.2241788531
Medicare,NSAID or no exposure,PsO/PsA,Psoriatic arthritis,17983,26122,12 months,815,3.1199754996
Medicare,NSAID or no exposure,PsO/PsA,Psoriatic arthritis,17983,26122,24 months,954,3.6520940204
Medicare,NSAID or no exposure,PsO/PsA,Psoriatic arthritis,17983,26122,36 months,1029,3.9392083301
Medicare,NSAID or no exposure,PsO/PsA,Psoriatic arthritis,17983,26122,AS cohort entry to exposure,640,2.4500421101
Medicare,NSAID or no exposure,Uveitis,Uveitis,17983,26122,12 months,914,3.4989663885
Medicare,NSAID or no exposure,Uveitis,Uveitis,17983,26122,24 months,1211,4.6359390552
Medicare,NSAID or no exposure,Uveitis,Uveitis,17983,26122,36 months,1380,5.2829032999
Medicare,NSAID or no exposure,Uveitis,Uveitis,17983,26122,AS cohort entry to exposure,758,2.9017686241
Medicare,TNF,Cancer,Hematologic Cancer,4866,5929,12 months,26,0.4385225164
Medicare,TNF,Cancer,Hematologic Cancer,4866,5929,24 months,44,0.7421150278
Medicare,TNF,Cancer,Hematologic Cancer,4866,5929,36 months,56,0.9445100354
Medicare,TNF,Cancer,Hematologic Cancer,4866,5929,AS cohort entry to exposure,28,0.4722550177
Medicare,TNF,Cancer,Non Melanoma Skin Cancer,4866,5929,12 months,72,1.2143700455
Medicare,TNF,Cancer,Non Melanoma Skin Cancer,4866,5929,24 months,116,1.9564850734
Medicare,TNF,Cancer,Non Melanoma Skin Cancer,4866,5929,36 months,153,2.5805363468
Medicare,TNF,Cancer,Non Melanoma Skin Cancer,4866,5929,AS cohort entry to exposure,69,1.1637712936
Medicare,TNF,Cancer,Solid Cancer,4866,5929,12 months,338,5.7007927138
Medicare,TNF,Cancer,Solid Cancer,4866,5929,24 months,422,7.1175577669
Medicare,TNF,Cancer,Solid Cancer,4866,5929,36 months,484,8.1632653061
Medicare,TNF,Cancer,Solid Cancer,4866,5929,AS cohort entry to exposure,291,4.9080789341
Medicare,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,4866,5929,12 months,174,2.9347276101
Medicare,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,4866,5929,24 months,239,4.0310339012
Medicare,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,4866,5929,36 months,276,4.6550851746
Medicare,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,4866,5929,AS cohort entry to exposure,172,2.9009951088
Medicare,TNF,Cardiac disease,Conduction Block,4866,5929,12 months,145,2.4456063417
Medicare,TNF,Cardiac disease,Conduction Block,4866,5929,24 months,210,3.5419126328
Medicare,TNF,Cardiac disease,Conduction Block,4866,5929,36 months,262,4.4189576657
Medicare,TNF,Cardiac disease,Conduction Block,4866,5929,AS cohort entry to exposure,131,2.2094788329
Medicare,TNF,Cardiac disease,Myocardial infarction,4866,5929,12 months,29,0.4891212683
Medicare,TNF,Cardiac disease,Myocardial infarction,4866,5929,24 months,62,1.0457075392
Medicare,TNF,Cardiac disease,Myocardial infarction,4866,5929,36 months,87,1.467363805
Medicare,TNF,Cardiac disease,Myocardial infarction,4866,5929,AS cohort entry to exposure,58,0.9782425367
Medicare,TNF,Infection,Hospitalized infection,4866,5929,12 months,542,9.1415078428
Medicare,TNF,Infection,Hospitalized infection,4866,5929,24 months,925,15.601281835
Medicare,TNF,Infection,Hospitalized infection,4866,5929,36 months,1132,19.092595716
Medicare,TNF,Infection,Hospitalized infection,4866,5929,AS cohort entry to exposure,673,11.350986676
Medicare,TNF,Infection,Opportunistic infection,4866,5929,12 months,161,2.7154663518
Medicare,TNF,Infection,Opportunistic infection,4866,5929,24 months,240,4.0479001518
Medicare,TNF,Infection,Opportunistic infection,4866,5929,36 months,287,4.8406139315
Medicare,TNF,Infection,Opportunistic infection,4866,5929,AS cohort entry to exposure,192,3.2383201214
Medicare,TNF,Inflammatory bowel disease,Crohn’s Disease,4866,5929,12 months,497,8.3825265643
Medicare,TNF,Inflammatory bowel disease,Crohn’s Disease,4866,5929,24 months,538,9.0740428403
Medicare,TNF,Inflammatory bowel disease,Crohn’s Disease,4866,5929,36 months,554,9.3439028504
Medicare,TNF,Inflammatory bowel disease,Crohn’s Disease,4866,5929,AS cohort entry to exposure,459,7.7416090403
Medicare,TNF,Inflammatory bowel disease,Ulcerative Colitis,4866,5929,12 months,229,3.8623713948
Medicare,TNF,Inflammatory bowel disease,Ulcerative Colitis,4866,5929,24 months,288,4.8574801822
Medicare,TNF,Inflammatory bowel disease,Ulcerative Colitis,4866,5929,36 months,314,5.2960026986
Medicare,TNF,Inflammatory bowel disease,Ulcerative Colitis,4866,5929,AS cohort entry to exposure,229,3.8623713948
Medicare,TNF,Kidney disease,Amyloidosis,4866,5929,12 months,6,0.1011975038
Medicare,TNF,Kidney disease,Amyloidosis,4866,5929,24 months,11,0.185528757
Medicare,TNF,Kidney disease,Amyloidosis,4866,5929,36 months,11,0.185528757
Medicare,TNF,Kidney disease,Amyloidosis,4866,5929,AS cohort entry to exposure,7,0.1180637544
Medicare,TNF,Kidney disease,IgA nephropathy,4866,5929,12 months,7,0.1180637544
Medicare,TNF,Kidney disease,IgA nephropathy,4866,5929,24 months,15,0.2529937595
Medicare,TNF,Kidney disease,IgA nephropathy,4866,5929,36 months,22,0.3710575139
Medicare,TNF,Kidney disease,IgA nephropathy,4866,5929,AS cohort entry to exposure,17,0.2867262608
Medicare,TNF,Kidney disease,Nephrotic syndrome,4866,5929,12 months,12,0.2023950076
Medicare,TNF,Kidney disease,Nephrotic syndrome,4866,5929,24 months,22,0.3710575139
Medicare,TNF,Kidney disease,Nephrotic syndrome,4866,5929,36 months,25,0.4216562658
Medicare,TNF,Kidney disease,Nephrotic syndrome,4866,5929,AS cohort entry to exposure,8,0.1349300051
Medicare,TNF,Lung disease,Interstitial lung disease,4866,5929,12 months,26,0.4385225164
Medicare,TNF,Lung disease,Interstitial lung disease,4866,5929,24 months,42,0.7083825266
Medicare,TNF,Lung disease,Interstitial lung disease,4866,5929,36 months,55,0.9276437848
Medicare,TNF,Lung disease,Interstitial lung disease,4866,5929,AS cohort entry to exposure,37,0.6240512734
Medicare,TNF,Lung disease,Restrictive lung disease ,4866,5929,12 months,145,2.4456063417
Medicare,TNF,Lung disease,Restrictive lung disease ,4866,5929,24 months,246,4.1490976556
Medicare,TNF,Lung disease,Restrictive lung disease ,4866,5929,36 months,295,4.9755439366
Medicare,TNF,Lung disease,Restrictive lung disease ,4866,5929,AS cohort entry to exposure,184,3.1033901164
Medicare,TNF,Neurological Disease,Cauda Equina syndrome,4866,5929,12 months,8,0.1349300051
Medicare,TNF,Neurological Disease,Cauda Equina syndrome,4866,5929,24 months,13,0.2192612582
Medicare,TNF,Neurological Disease,Cauda Equina syndrome,4866,5929,36 months,14,0.2361275089
Medicare,TNF,Neurological Disease,Cauda Equina syndrome,4866,5929,AS cohort entry to exposure,3,0.0505987519
Medicare,TNF,Neurological Disease,Spinal Cord compression,4866,5929,12 months,15,0.2529937595
Medicare,TNF,Neurological Disease,Spinal Cord compression,4866,5929,24 months,22,0.3710575139
Medicare,TNF,Neurological Disease,Spinal Cord compression,4866,5929,36 months,31,0.5228537696
Medicare,TNF,Neurological Disease,Spinal Cord compression,4866,5929,AS cohort entry to exposure,23,0.3879237645
Medicare,TNF,Osteoporotic fracture,Clinical vertebral fracture,4866,5929,12 months,109,1.8384213189
Medicare,TNF,Osteoporotic fracture,Clinical vertebral fracture,4866,5929,24 months,187,3.1539888683
Medicare,TNF,Osteoporotic fracture,Clinical vertebral fracture,4866,5929,36 months,242,4.0816326531
Medicare,TNF,Osteoporotic fracture,Clinical vertebral fracture,4866,5929,AS cohort entry to exposure,170,2.8672626075
Medicare,TNF,Osteoporotic fracture,Non-vertebral osteoporotic fracture,4866,5929,12 months,172,2.9009951088
Medicare,TNF,Osteoporotic fracture,Non-vertebral osteoporotic fracture,4866,5929,24 months,286,4.8237476809
Medicare,TNF,Osteoporotic fracture,Non-vertebral osteoporotic fracture,4866,5929,36 months,382,6.4429077416
Medicare,TNF,Osteoporotic fracture,Non-vertebral osteoporotic fracture,4866,5929,AS cohort entry to exposure,247,4.1659639062
Medicare,TNF,PsO/PsA,Psoriasis,4866,5929,12 months,416,7.0163602631
Medicare,TNF,PsO/PsA,Psoriasis,4866,5929,24 months,519,8.7535840783
Medicare,TNF,PsO/PsA,Psoriasis,4866,5929,36 months,568,9.5800303593
Medicare,TNF,PsO/PsA,Psoriasis,4866,5929,AS cohort entry to exposure,392,6.6115702479
Medicare,TNF,PsO/PsA,Psoriatic arthritis,4866,5929,12 months,624,10.524540395
Medicare,TNF,PsO/PsA,Psoriatic arthritis,4866,5929,24 months,706,11.907572947
Medicare,TNF,PsO/PsA,Psoriatic arthritis,4866,5929,36 months,755,12.734019228
Medicare,TNF,PsO/PsA,Psoriatic arthritis,4866,5929,AS cohort entry to exposure,619,10.440209142
Medicare,TNF,Uveitis,Uveitis,4866,5929,12 months,408,6.8814302581
Medicare,TNF,Uveitis,Uveitis,4866,5929,24 months,511,8.6186540732
Medicare,TNF,Uveitis,Uveitis,4866,5929,36 months,585,9.86675662
Medicare,TNF,Uveitis,Uveitis,4866,5929,AS cohort entry to exposure,447,7.5392140327
